| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |